Related Experiment Video
Updated: Nov 17, 2025
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
Human induced pluripotent stem cell-based platform for modeling cardiac ischemia
Martta Häkli1, Joose Kreutzer2, Antti-Juhana Mäki2
1Heart Group, Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland. martta.hakli@tuni.fi.
Insights
Developing a human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) model for cardiac ischemia-reperfusion injury provides a new platform for drug discovery. This model accurately mimics human heart responses to ischemia and reperfusion, overcoming limitations of previous animal studies.
Area of Science:
- Cardiovascular Biology
- Stem Cell Research
- Disease Modeling
Background:
- Ischemic heart disease is a leading global cause of mortality.
- Current therapeutic strategies, primarily reperfusion, can exacerbate tissue damage.
- Existing animal models often fail to accurately predict human responses to ischemia-reperfusion injury, necessitating human-based models.
Purpose of the Study:
- To develop a human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM)-based platform for modeling cardiac ischemia-reperfusion (I/R) injury.
- To precisely control oxygen levels and monitor hiPSC-CM functionality during simulated I/R.
- To evaluate hiPSC-CM responses, including morphology and gene/protein expression, to hypoxia and reoxygenation.
Main Methods:
- Established a hiPSC-CM platform with controlled oxygen concentration and real-time monitoring.
- Exposed hiPSC-CMs to 8 or 24 hours of hypoxia followed by 24 hours of reoxygenation.
- Assessed beating frequency, field potential propagation, depolarization time, field potential duration, sarcomere structure, and gene/protein expression.
Main Results:
- Hypoxia initially decreased hiPSC-CM beating frequency, followed by adaptation and increased beating before reoxygenation.
- Reoxygenation caused transient increases in beating frequency above baseline.
- Hypoxia led to slowed field potential propagation, increased depolarization time, and decreased field potential duration, which reversed upon reoxygenation. Sarcomere disorganization and altered gene expression (e.g., glucose transporter 1) were observed.
Conclusions:
- hiPSC-CMs, despite their immature phenotype, serve as a viable model for studying cardiac ischemia-reperfusion injury.
- The developed platform allows for precise control and monitoring of I/R conditions in a human-relevant system.
- This model holds promise for advancing the development of effective therapeutics for ischemic heart disease.
Abstract:
Ischemic heart disease is a major cause of death worldwide, and the only available therapy to salvage the tissue is reperfusion, which can initially cause further damage. Many therapeutics that have been promising in animal models have failed in human trials. Thus, functional human based cardiac ischemia models are required. In this study, a human induced pluripotent stem cell derived-cardiomyocyte (hiPSC-CM)-based platform for modeling ischemia-reperfusion was developed utilizing a system enabling precise control over oxygen concentration and real-time monitoring of the oxygen dynamics as well as iPS-CM functionality. In addition, morphology and expression of hypoxia-related genes and proteins were evaluated as hiPSC-CM response to 8 or 24 h hypoxia and 24 h reoxygenation. During hypoxia, initial decrease in hiPSC-CM beating frequency was observed, after which the CMs adapted to the conditions and the beating frequency gradually increased already before reoxygenation. During reoxygenation, the beating frequency typically first surpassed the baseline before settling down to the values close the baseline. Furthermore, slowing on the field potential propagation throughout the hiPSC-CM sheet as well as increase in depolarization time and decrease in overall field potential duration were observed during hypoxia. These changes were reversed during reoxygenation. Disorganization of sarcomere structures was observed after hypoxia and reoxygenation, supported by decrease in the expression of sarcomeric proteins. Furthermore, increase in the expression of gene encoding glucose transporter 1 was observed. These findings indicate, that despite their immature phenotype, hiPSC-CMs can be utilized in modeling ischemia-reperfusion injury.
